$8.29 (-0.480%)

Volume: 295.341k

Closed: May 26, 2023

Hollow Logo Score: -1.900
Aclaris Therapeutics Stock
$8.29 (-0.480%)

Volume: 295.341k

Closed: May 26, 2023

Score Hollow Logo -1.900

Aclaris Therapeutics Stock Statistics

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Dates Signal Change
2023-05-24 - 2023-05-26 SELL -1.89
2023-05-23 - 2023-05-24 HOLD -1.05
2023-05-18 - 2023-05-23 SELL 5.17
2023-05-17 - 2023-05-18 HOLD -2.29
2023-05-16 - 2023-05-17 SELL 1.59

Stock Score Effectiveness

Bollinger Stock Signal Effectiveness

Macd Signal Effectiveness

Mv7 Signal Effectiveness

Score signal

Bollinger Signal Statistics

MV signal statistics

MACD Signal Statistics

Click to get the best stock tips daily for free!

About Aclaris Therapeutics

Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of... ACRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE